HIKMA Pharmaceuticals PLC
Develops and manufactures generic, branded, and specialty pharmaceutical products.
HIK | IL
Overview
Corporate Details
- ISIN(s):
- GB00B0LCW083
- LEI:
- 549300BNS685UXH4JI75
- Country:
- United Kingdom
- Address:
- 1 New Burlington Place, W1S 2HR London
- Website:
- https://www.hikma.com/home/
- Sector:
- Manufacturing
Description
Hikma Pharmaceuticals is a global pharmaceutical company that develops, manufactures, and markets a broad portfolio of pharmaceutical products. The company's offerings include a wide range of generic, branded, specialty, and in-licensed medicines. It is a significant supplier of generic injectable products to hospitals and also provides oral generics and other specialty medications. With a focus on producing high-quality medicines, Hikma aims to make its products accessible to patients and healthcare providers across its key markets in North America, Europe, and the Middle East & North Africa (MENA) region.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-11 13:25 |
Holding(s) in Company
|
English | 69.4 KB | ||
| 2025-11-11 12:55 |
Director/PDMR Shareholding
|
English | 18.5 KB | ||
| 2025-11-07 14:10 |
Director/PDMR Shareholding
|
English | 21.3 KB | ||
| 2025-11-06 08:20 |
November Trading Statement
|
English | 23.5 KB | ||
| 2025-08-22 13:02 |
Director/PDMR Shareholding
|
English | 14.5 KB | ||
| 2025-08-13 14:51 |
Director/PDMR Shareholding
|
English | 17.9 KB | ||
| 2025-08-08 13:59 |
Director/PDMR Shareholding
|
English | 14.6 KB | ||
| 2025-08-07 08:00 |
Half-year Report
|
English | 884.0 KB | ||
| 2025-07-09 10:00 |
Notice of Results
|
English | 12.9 KB | ||
| 2025-07-07 10:16 |
Publication of Offering Circular
|
English | 8.0 KB | ||
| 2025-06-05 15:05 |
Director/PDMR Shareholding
|
English | 14.4 KB | ||
| 2025-06-03 14:02 |
Director/PDMR Shareholding
|
English | 89.1 KB | ||
| 2025-05-29 08:00 |
Fitch upgrades Hikma to ‘BBB’
|
English | 11.3 KB | ||
| 2025-05-15 13:00 |
Medium-term Group guidance ahead of US site visit
|
English | 12.5 KB | ||
| 2025-05-08 11:48 |
S&P upgrades Hikma to ‘BBB’
|
English | 11.3 KB |
Automate Your Workflow. Get a real-time feed of all HIKMA Pharmaceuticals PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HIKMA Pharmaceuticals PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HIKMA Pharmaceuticals PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
